Dylan Dupuis
Stock Analyst at Roth MKM
(2.78)
# 1,878
Out of 4,944 analysts
8
Total ratings
50%
Success rate
43.19%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Dylan Dupuis
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CMMB Chemomab Therapeutics | Reinstates: Buy | $7 | $0.96 | +630.69% | 2 | Dec 19, 2023 | |
| IVA Inventiva | Reiterates: Buy | $11 | $4.02 | +173.63% | 2 | Sep 21, 2023 | |
| TERN Terns Pharmaceuticals | Reiterates: Buy | $23 | $6.49 | +254.39% | 3 | Aug 8, 2023 | |
| VKTX Viking Therapeutics | Assumes: Buy | $32 | $41.27 | -22.46% | 1 | May 31, 2023 |
Chemomab Therapeutics
Dec 19, 2023
Reinstates: Buy
Price Target: $7
Current: $0.96
Upside: +630.69%
Inventiva
Sep 21, 2023
Reiterates: Buy
Price Target: $11
Current: $4.02
Upside: +173.63%
Terns Pharmaceuticals
Aug 8, 2023
Reiterates: Buy
Price Target: $23
Current: $6.49
Upside: +254.39%
Viking Therapeutics
May 31, 2023
Assumes: Buy
Price Target: $32
Current: $41.27
Upside: -22.46%